BG103632A - Фармацевтични състави, съдържащи ибупрофен и домперидон, за лечение на мигрена - Google Patents

Фармацевтични състави, съдържащи ибупрофен и домперидон, за лечение на мигрена

Info

Publication number
BG103632A
BG103632A BG103632A BG10363299A BG103632A BG 103632 A BG103632 A BG 103632A BG 103632 A BG103632 A BG 103632A BG 10363299 A BG10363299 A BG 10363299A BG 103632 A BG103632 A BG 103632A
Authority
BG
Bulgaria
Prior art keywords
ibuprophene
domperidon
pharmaceutical compositions
compositions containing
migraine treatment
Prior art date
Application number
BG103632A
Other languages
English (en)
Other versions
BG64371B1 (bg
Inventor
Mahendra Pankhania
Saruhan Yurdakul
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG103632A publication Critical patent/BG103632A/bg
Publication of BG64371B1 publication Critical patent/BG64371B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Фармацевтичният състав съдържа ибупрофен или негова сол от 200 до 3200 mg и домперидон или негова сол от 10 до 100 mg и се използва за лечение на мигрена.
BG103632A 1997-02-06 1999-08-03 Фармацевтични състави, съдържащи ибупрофен и домперидон, за лечение на мигрена BG64371B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9702392.3A GB9702392D0 (en) 1997-02-06 1997-02-06 Therapeutic agents

Publications (2)

Publication Number Publication Date
BG103632A true BG103632A (bg) 2000-03-31
BG64371B1 BG64371B1 (bg) 2004-12-30

Family

ID=10807167

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103632A BG64371B1 (bg) 1997-02-06 1999-08-03 Фармацевтични състави, съдържащи ибупрофен и домперидон, за лечение на мигрена

Country Status (25)

Country Link
EP (1) EP1017388B1 (bg)
JP (1) JP2001511168A (bg)
KR (1) KR20000070823A (bg)
CN (1) CN1115150C (bg)
AR (1) AR011437A1 (bg)
AT (1) ATE247466T1 (bg)
AU (1) AU724526B2 (bg)
BG (1) BG64371B1 (bg)
CA (1) CA2279184C (bg)
CZ (1) CZ295374B6 (bg)
DE (1) DE69817379T2 (bg)
DK (1) DK1017388T3 (bg)
ES (1) ES2205452T3 (bg)
GB (2) GB9702392D0 (bg)
HU (1) HU225043B1 (bg)
ID (1) ID22416A (bg)
IL (1) IL131230A0 (bg)
NO (1) NO993784L (bg)
PL (1) PL190733B1 (bg)
PT (1) PT1017388E (bg)
RU (1) RU2195935C2 (bg)
SK (1) SK284728B6 (bg)
TR (1) TR199901782T2 (bg)
WO (1) WO1998034612A1 (bg)
ZA (1) ZA98968B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
GB9822333D0 (en) * 1998-10-13 1998-12-09 Merck Sharp & Dohme Pharmaceutical formulation
ES2263510T3 (es) * 1999-12-09 2006-12-16 Reckitt Benckiser Healthcare (Uk) Limited Preparacion en comprimidos que comprende un antiinflamatorio no esteroideo (aine).
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
ZA200702694B (en) * 2004-09-30 2008-07-30 Scolr Pharma Inc Modified release ibuprofen dosage form
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
DE102005013726A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Transdermale therapeutische Systeme mit verbesserter Verträglichkeit
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2008134540A1 (en) * 2007-04-26 2008-11-06 Aronchick Craig A Compositions and methods for transmucosal delivery of domperidone
CN107773560A (zh) * 2016-08-25 2018-03-09 厦门恩成制药有限公司 一种具有止痛和消炎作用的药用组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
NO993784D0 (no) 1999-08-05
SK106299A3 (en) 2000-08-14
HUP0001104A2 (hu) 2000-08-28
HU225043B1 (en) 2006-05-29
CN1246795A (zh) 2000-03-08
ZA98968B (en) 1998-08-06
DK1017388T3 (da) 2003-10-13
JP2001511168A (ja) 2001-08-07
IL131230A0 (en) 2001-01-28
NO993784L (no) 1999-09-22
TR199901782T2 (xx) 1999-09-21
CZ270999A3 (cs) 1999-10-13
EP1017388A1 (en) 2000-07-12
CA2279184A1 (en) 1998-08-13
PT1017388E (pt) 2003-12-31
GB2331926A (en) 1999-06-09
ATE247466T1 (de) 2003-09-15
AR011437A1 (es) 2000-08-16
HUP0001104A3 (en) 2000-09-28
ES2205452T3 (es) 2004-05-01
RU2195935C2 (ru) 2003-01-10
CZ295374B6 (cs) 2005-07-13
GB9702392D0 (en) 1997-03-26
DE69817379D1 (de) 2003-09-25
PL335089A1 (en) 2000-04-10
CA2279184C (en) 2009-04-21
BG64371B1 (bg) 2004-12-30
GB2331926B (en) 2000-07-12
GB9904285D0 (en) 1999-04-21
WO1998034612A1 (en) 1998-08-13
EP1017388B1 (en) 2003-08-20
AU6295598A (en) 1998-08-26
DE69817379T2 (de) 2004-06-09
ID22416A (id) 1999-10-14
PL190733B1 (pl) 2005-12-30
KR20000070823A (ko) 2000-11-25
CN1115150C (zh) 2003-07-23
SK284728B6 (sk) 2005-10-06
AU724526B2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BG102425A (bg) (метилсулфонил)фенил-2-(5н)-фуранони като инхибитори на циклооксигеназа-2
EP0705100A4 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
BG101841A (bg) Инхибитори на клетъчна адхезия
MX9704735A (es) Formulaciones para reducir irritacion de la piel y el uso de las mismas.
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
NZ330667A (en) Use of substituted 2,4-imadazolidinedione compounds as analgesics
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
BG105256A (bg) Мускаринови агонисти и антагонисти
BG102250A (bg) Използване на гликозиди, извлечени от невен, за лечение на псориаза
BG103632A (bg) Фармацевтични състави, съдържащи ибупрофен и домперидон, за лечение на мигрена
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
MX9709451A (es) Derivados de benzisoxazol e indazol como agentes antipsicoticos.
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
UA48962C2 (uk) Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
GB9015774D0 (en) Novel treatment